8-K: GoHealth Faces Nasdaq Delisting Threat Over MVLS, Equity

GoHealth, Inc. received a Nasdaq notice for non-compliance with listing rules, including minimum market value, stockholders' equity, and net income requirements.

Summary

• GoHealth, Inc. (GOCO) received a written notice from Nasdaq on March 18, 2026, indicating non-compliance with several listing rules.
• The company failed to meet Nasdaq Listing Rule 5550(b)(2), which requires a minimum market value of listed securities (MVLS) of $35 million.
• GoHealth also does not meet alternative continued listing standards, specifically Nasdaq Listing Rule 5550(b)(1) for stockholders' equity of at least $2.5 million.
• Additionally, the company failed to meet Nasdaq Listing Rule 5550(b)(3) for net income from continuing operations of $500,000 in the most recently completed fiscal year or in two of the three most recently completed fiscal years.
• The notice does not immediately affect the trading of GOCO common stock on The Nasdaq Global Market.
• GoHealth has a compliance period of 180 calendar days, until September 14, 2026, to regain compliance with the MVLS Requirement.
• To regain compliance, the company's market value of listed securities must close at $35 million or more for a minimum of 10 consecutive business days.
• Failure to regain compliance could lead to a delisting notice from Nasdaq, which the company may appeal to a Nasdaq Hearings Panel.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a highly negative development, indicating severe financial distress and a significant risk of delisting, which could lead to substantial shareholder value erosion.

Positives

• The notice has no immediate effect on the listing or trading of GoHealth's common stock.
• GoHealth has a 180-day compliance period, until September 14, 2026, to address the MVLS deficiency.
• The company retains the right to appeal any delisting determination to a Nasdaq Hearings Panel, which would stay any suspension or delisting action.

Negatives

• GoHealth is not in compliance with Nasdaq Listing Rule 5550(b)(2) requiring a minimum market value of listed securities of $35 million.
• The company does not meet Nasdaq Listing Rule 5550(b)(1) requiring stockholders' equity of at least $2.5 million.
• GoHealth also fails to meet Nasdaq Listing Rule 5550(b)(3) requiring net income from continuing operations of $500,000 in the most recently completed fiscal year or in two of the three most recently completed fiscal years.
• There is no assurance that the company will be able to regain compliance with the applicable continued listing requirements.

Risks

• Potential delisting of the company's common stock from The Nasdaq Global Market if compliance is not regained.
• Uncertainty regarding the company's ability to regain compliance with Nasdaq's MVLS, stockholders' equity, and net income requirements.
• Risks associated with the company's business in general, as detailed in previous SEC filings (Form 10-K for December 31, 2024, Form 10-Q, and other 8-K filings).

Future Outlook

GoHealth is evaluating options to regain compliance with the MVLS Requirement and maintain its listing on The Nasdaq Global Market. However, there is no assurance that the company will be able to regain compliance with the applicable continued listing requirements.

Management Comments

• The Company is evaluating options to regain compliance with the MVLS Requirement.
• There can be no assurance that the Company will be able to regain compliance with the applicable continued listing requirements.

Industry Context

StockSavvy.ai notes that non-compliance with listing standards, particularly related to market capitalization and financial health, is a significant red flag for companies in any industry. For a company like GoHealth, operating in the competitive health insurance marketplace, such a notice can further erode investor confidence and potentially impact its ability to attract and retain talent or secure favorable business partnerships, especially if delisting becomes a reality. This situation highlights broader market pressures on smaller or underperforming public companies.

Comparison to Industry Standards

• StockSavvy.ai observes that maintaining minimum listing standards is a fundamental requirement for public companies across global exchanges. Companies like GoHealth failing to meet market value, equity, and net income thresholds are significantly underperforming compared to industry peers that successfully maintain their listing status.
• For instance, while larger health insurance brokers or technology platforms (e.g., eHealth, SelectQuote) typically maintain market capitalizations well above the $35 million threshold, GoHealth's current position indicates a severe valuation decline or sustained operational losses that place it far below these benchmarks.
• The inability to meet basic financial health metrics like $2.5 million in stockholders' equity or $500,000 in net income suggests a fundamental weakness in financial performance that is not typical for a healthy, publicly traded entity in the financial or healthcare services sector.

Stakeholder Impact

• Shareholders face significant risk of value erosion and loss of liquidity due to potential delisting.
• Employees may experience uncertainty regarding the company's future and job security.
• Creditors may view the company as a higher risk, potentially impacting future financing terms.
• Customers and business partners might perceive the company as less stable, affecting future relationships.

Next Steps

• GoHealth must regain compliance with Nasdaq's MVLS Requirement by September 14, 2026.
• The company needs to achieve a market value of listed securities of $35 million or more for at least 10 consecutive business days.
• If compliance is not regained, GoHealth may receive a delisting notice and can appeal to a Nasdaq Hearings Panel.

Key Dates

Recommendation

The filing reveals GoHealth's severe non-compliance with multiple critical Nasdaq listing standards, including market value, stockholders' equity, and net income. The explicit statement that there is no assurance of regaining compliance, coupled with the looming delisting threat, indicates fundamental financial weakness and a high probability of significant share price decline and liquidity issues. A seasoned investor would view this as a strong signal to exit the position.

Keywords

GoHealth, GOCO, Nasdaq, Delisting, Compliance, Market Value of Listed Securities, MVLS, Stockholders' Equity, Net Income, SEC Filing, 8-K